Genus Research News Today

Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) and Genus (OTCMKTS:GENSF – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk. Analyst Ratings This is a summary of current ratings […]

Genus plc (LON:GNS – Get Free Report) announced a dividend on Thursday, February 22nd, Upcoming.Co.Uk reports. Stockholders of record on Thursday, February 29th will be paid a dividend of GBX 10.30 ($0.13) per share on Thursday, March 28th. This represents a dividend yield of 0.54%. The ex-dividend date of this dividend is Thursday, February 29th. […]

Genus plc (LON:GNS – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,201.40 ($27.97) and traded as high as GBX 2,378 ($30.22). Genus shares last traded at GBX 2,342 ($29.76), with a volume of 83,387 shares traded. Genus Stock […]

Genus plc (OTCMKTS:GENSF – Get Free Report) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 2,200 shares, a decrease of 18.5% from the December 15th total of 2,700 shares. Based on an average trading volume of 100 shares, the […]

Genus plc (OTCMKTS:GENSF – Get Free Report) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 400 shares, an increase of 33.3% from the October 31st total of 300 shares. Based on an average daily volume of 200 shares, the short-interest ratio is […]

Genus plc (LON:GNS – Get Free Report) declared a dividend on Thursday, September 7th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, November 9th will be given a dividend of GBX 21.70 ($0.27) per share on Friday, December 8th. This represents a yield of 0.97%. The ex-dividend date is Thursday, November 9th. This is a boost […]

Genus plc (LON:GNS – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 2,084 ($26.32) and last traded at GBX 2,100 ($26.52), with a volume of 11127 shares changing hands. The stock had previously closed at GBX 2,234 ($28.21). Wall Street Analyst […]

Genus (OTCMKTS:GENSF – Free Report) is one of 387 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Genus to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability. Analyst Recommendations This is a summary of […]

Genus (OTCMKTS:GENSF – Get Rating) is one of 403 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Genus to related businesses based on the strength of its profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation. Earnings and Valuation This table compares Genus […]

Genus (OTCMKTS:GENSF – Get Rating) is one of 346 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Genus to similar companies based on the strength of its dividends, valuation, earnings, analyst recommendations, risk, profitability and institutional ownership. Valuation & Earnings This table compares Genus […]